Roivant Sciences ROIV
NASDAQ ROIV
$34.94 +0.53 (+1.54%)
As of: Sep 4, 2026 · 3:59 PM EDT

Roivant Sciences (ROIV) Other Working Capital Changes (2020 - 2026)

Roivant Sciences' (ROIV) quarterly Other Working Capital Changes came in at -$2.1 million in Q4 2025, up 61.35% YoY from -$1.3 million in Q4 2024, and down 165.83% on a QoQ basis from $3.2 million in Q3 2025.

Analysis

Roivant Sciences (ROIV) Other Working Capital Changes (2020 - 2026) Analysis & Trends

Roivant Sciences (ROIV) has 6 years of Other Working Capital Changes data on file, last reported at -$2.1 million in Q4 2025.

  • Quarterly Other Working Capital Changes rose 61.35% year-over-year to -$2.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$4.3 million (up 91.56% YoY) and the FY2026 annual result came in at -$2.4 million, up 58.16% from the prior year.
  • Other Working Capital Changes fell to -$2.1 million in Q4 2025, from $3.2 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $53.9 million in Q4 2024 to a low of -$4.1 million in Q3 2024.
  • A 5-year average of $13.2 million and a median of $11.3 million in 2022 frame the typical range for Other Working Capital Changes.
  • Annual changes were most pronounced in 2023 — Other Working Capital Changes slumped 1156.31% — and 2024, when it jumped 170.26%.
  • Tracing ROIV's Other Working Capital Changes over 5 years: stood at -$6.2 million in 2021, then surged by 45.84% to -$3.3 million in 2022, then tumbled by 1156.31% to -$42.0 million in 2023, then jumped by 87.0% to -$5.5 million in 2024, then soared by 61.35% to -$2.1 million in 2025.
  • The last three Other Working Capital Changes figures came in at -$2.1 million (Q4 2025), $3.2 million (Q3 2025), and $71000.0 (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Roivant Sciences 25.18 Bn 25.18 Bn 1.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -286,000.00
Jun 30, 2026 -286,000.00
Dec 31, 2025 -2.11 Mn
Dec 31, 2025 -2.11 Mn
Sep 30, 2025 -846,000.00
Sep 30, 2025 -846,000.00
Jun 30, 2025 -478,000.00
Jun 30, 2025 -478,000.00
Dec 31, 2024 -5.46 Mn
Dec 31, 2024 -5.46 Mn
Sep 30, 2024 -1.63 Mn
Sep 30, 2024 -1.63 Mn
Jun 30, 2024 -1.82 Mn
Jun 30, 2024 -1.82 Mn
Dec 31, 2023 -6.15 Mn
Dec 31, 2023 -6.15 Mn
Sep 30, 2023 -2.15 Mn
Sep 30, 2023 -2.15 Mn
Jun 30, 2023 -2.01 Mn
Jun 30, 2023 -2.01 Mn